Workup for Acute Decompensated Heart Failure
For patients presenting with acute decompensated heart failure, immediately obtain: ECG, chest x-ray, serum creatinine, electrolytes (sodium, potassium, magnesium), troponin, complete blood count, and BNP or NT-proBNP levels 1, 2. If no recent echocardiogram is available, obtain one during the hospitalization 1.
Initial Diagnostic Assessment
Laboratory Testing (Class I, Level C)
Essential labs to order immediately:
- Renal function: Serum creatinine and BUN to assess kidney function and guide diuretic dosing
- Electrolytes: Sodium, potassium, and magnesium (critical before and during diuretic therapy)
- Cardiac biomarkers: Troponin to identify acute coronary syndrome as a precipitant
- Natriuretic peptides: BNP or NT-proBNP for diagnostic confirmation and prognostic stratification
- Complete blood count: To identify anemia (hemoglobin <110 g/L is associated with worse outcomes) 1
BNP/NT-proBNP Interpretation
For ruling out heart failure 1:
- BNP <100 pg/mL indicates low probability of acute heart failure
- NT-proBNP <300 pg/mL (regardless of age) has 99% negative predictive value
For ruling in heart failure 1:
- BNP >500 pg/mL indicates very high probability
- NT-proBNP >450 pg/mL (age <50 years) or >900 pg/mL (age ≥50 years) confirms diagnosis
Important caveats: BNP may be falsely low in obesity and "flash" pulmonary edema (insufficient time for ventricular release). BNP may be falsely elevated in renal failure, sepsis, and advanced age 1.
Cardiac Testing
- Identify arrhythmias (atrial fibrillation accounts for ~30% of decompensations)
- Detect acute ischemia/infarction (another ~30% of cases)
- Look for conduction abnormalities
Chest radiography 3:
- Assess heart size and pulmonary congestion
- Identify pleural effusions
- Rule out alternative pulmonary pathology (pneumonia, COPD exacerbation)
- Determine left ventricular ejection fraction (LVEF ≤40% vs preserved)
- Assess valvular function (valvular dysfunction causes ~30% of decompensations)
- Evaluate wall motion abnormalities suggesting ischemia
- Measure chamber sizes and wall thickness
Hemodynamic Profiling
Clinically assess the patient's hemodynamic profile 1, 2:
Congestion Assessment (Wet vs Dry)
Look for:
- Left-sided congestion: Orthopnea, paroxysmal nocturnal dyspnea, breathlessness, bi-basilar rales
- Right-sided congestion: Jugular venous distension, hepatojugular reflux, hepatomegaly, peripheral edema, ascites
Perfusion Assessment (Warm vs Cold)
Look for:
- Adequate perfusion (warm): Normal blood pressure, warm extremities, normal mentation
- Hypoperfusion (cold): Narrow pulse pressure, cool extremities, altered mentation, elevated lactate 2
Critical point: Up to 25% of patients have mismatch between right- and left-sided filling pressures, which can hinder effective decongestion 2. Disproportionate right-sided pressure elevation may occur without obvious jugular venous distension.
Identify Precipitating Factors (Class I, Level C)
Systematically search for triggers 1, 2:
Most Common Precipitants (each ~30% of cases):
- Arrhythmias (especially atrial fibrillation)
- Acute coronary syndrome/ischemia
- Valvular dysfunction
Other Important Triggers:
- Uncontrolled hypertension
- Medication nonadherence
- Dietary sodium indiscretion
- Acute infections (pneumonia, urinary tract infection)
- Anemia
- Thyroid dysfunction (hyper- or hypothyroidism)
- Nephrotoxic medications (NSAIDs)
- Negative inotropic drugs (verapamil, diltiazem)
Additional Workup in Select Patients
When to Consider Invasive Hemodynamic Monitoring (Right-Heart Catheterization) 4
Indicated in:
- Cardiogenic shock requiring escalating pressors
- Severe decompensation where therapy is limited by uncertain contributions of elevated filling pressures vs hypoperfusion
- Apparent dependence on IV inotropes after initial improvement
- Persistent severe symptoms despite adjustment of recommended therapies
Not recommended: Routine use in normotensive patients responding symptomatically to diuretics and vasodilators 4.
When to Consider Coronary Angiography 4
- Patients with angina or suspected acute coronary syndrome
- New-onset heart failure without clear etiology
- Clinical deterioration suggesting interim ischemic disease
Special Populations
Anemia workup 1: If hemoglobin <110 g/L or hematocrit <35%, evaluate for:
- Chronic blood loss
- Iron deficiency
- Vitamin B12 or folate deficiency
- Inflammatory illness
Monitoring During Hospitalization
Serial monitoring should include 5:
- Daily weights
- Strict intake/output measurement
- Urine output monitoring (target ≥100-150 mL/hour after diuretics) 6
- Renal function and electrolytes (recheck within 1-7 days after diuretic intensification, sooner in advanced heart failure) 1
- Symptoms and clinical signs of congestion
- Blood pressure (especially during vasodilator therapy)
Common pitfall: Acute renal dysfunction is defined as serum creatinine increase >30% from baseline over several days 1. Don't routinely discontinue GDMT for mild decreases in renal function or asymptomatic blood pressure reduction 2.
Risk Stratification
Elevated troponin and higher natriuretic peptide levels indicate worse prognosis 3, 1. These biomarkers help guide intensity of monitoring and treatment escalation decisions.
The 2016 ESC guidelines 5 and 2022 AHA/ACC/HFSA guidelines 2 provide the most comprehensive and recent framework, emphasizing early identification of hemodynamic profile, aggressive search for precipitants, and prompt initiation of appropriate therapy based on congestion and perfusion status.